Právní předpis byl sestaven k datu 25.10.2026.
Zobrazené znění právního předpisu je účinné od 24.11.2011.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2012
325/2011 Sb.
325
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
ze xxx 1. xxxxxxxxx 2011
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, zvláštní x xxxxxxxxx očkování xxx xxx 2012
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 odst. 1 xxxx. e) xxxxxx x. 258/2000 Xx., o xxxxxxx xxxxxxxxx zdraví a x změně xxxxxxxxx xxxxxxxxxxxxx zákonů, ve xxxxx xxxxxx x. 298/2011 Sb., stanoví xx základě doporučení Xxxxxxx xxxxxxxxxx komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x mimořádná xxxxxxxx pro xxx 2012:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) kombinovaná xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxxxxxx membranae xxxxxxxx proteinum
Diphtheriae xxxxxxxxxx
Xxxxxx xxxxxxxxxx xxx.
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B biosyntheticum
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1
Virus xxxxxxxxxxxxxxx xxxxxxxxxxx typus 2
Virus poliomyelitidis xxxxxxxxxxx xxxxx 3
Xxxxxxxxxx Hib: Polyribosylribitoli xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Tetani anatoxinum
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 25 xxxxxxxxxx
Pertactinum (69xX) 8 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx b (XXxXXxx):
Xxxxxxxxxxx xxxxxxxxxx | min. 30 mezinárodních xxxxxxxx |
Xxxxxx xxxxxxxxxx | xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
Xxxxxxxxx xxxxxxxxxx (XX) | 25 xxxxxxxxxx |
Pertussis xxxxxxxxxxxxxxx filamentosum | (XXX) 25 xxxxxxxxxx |
Pertactinum (69xX) | 8 xxxxxxxxxx |
Xxxxxxxxxxx xxxxxxxxxx X | 10 xxxxxxxxxx |
xxx xxxxxxxxx xxxxxxxx | 20-40 xxxxxxxxxx |
1x) očkovací xxxxx proti xxxxxxx x xxxxxx - xxxxxxxxx:
Xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx .................. xxx. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxxx xxxxxx purificatum ........................... xxx. 40 xxxxxxxxxxxxx jednotek
1e) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x:
1 dávka xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Anatoxino xxxxxxxx (30 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx ............................................. min. 40 mezinárodních jednotek
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X v dětské xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X x xxxxxxx xxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X
1xx) očkovací xxxxx proti xxxxxxxxxx, xxxxxxxxxx a zarděnkám:
Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50 Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx50 Rubeolae xxxxx attenuatum (Wistar XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50
1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx poliomyelitis xxxxxxxxxxx typus 1 (Xxxxxxx) ..... 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (MEF-1) .......... 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 3 (Xxxxxxx) ...... 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx ekvivalentních antigenů xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx látka proti xxxxxxx xxxxxxxxx Streptococcus xxxxxxxxxx x polysacharidové xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6B, 7X, 8, 9N, 9V, 1XX, 11 X, 12X, 14, 15B, 17X,
18X, 19X, 19X, 20, 22F, 23X, 33F ................ 25 xxxxxxxxxx x xxxxxxx xxxxxxxx
1x) xxxxxxxx látka xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Pneumococcale polysaccharidum xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A
Pneumococcale xxxxxxxxxxxxxxx sérotypus 6B
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 7X
Pneumococcale polysaccharidum xxxxxxxxx 9V
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Diphtheriae anatoxinum xx xxxx xxx 2 mezinárodní xxxxxxxx
Xxxxxx xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx
Pertusové xxxxxxxx:
Xxxxxxxxx anatoxinum .......... 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx 8 mikrogramů
Pertaktin .................... 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx) .... 40 X xxxxxxxx antigenu
xxxxx 2 (kmen XXX-1) ......... 8 X jednotek xxxxxxxx
xxxxx 3 (kmen Xxxxxxx) ...... 32 X xxxxxxxx xxxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):
Difterický xxxxxx | xxxx xxxx xxxxx 2 mezinárodní xxxxxxxx (2 Lf) | ||
Xxxxxxxxx xxxxxx | xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Lf) | ||
Xxxxxxxxx xxxxxxxx: | |||
Xxxxxxxxx xxxxxx | 2,5 xxxxxxxxxx | ||
Xxxxxxxxxxxx xxxxxxxxxxxx | 5 xxxxxxxxxx | ||
Xxxxxxx xxxx 2+3 | 5 xxxxxxxxxx | ||
Xxxxxxxxx | 3 xxxxxxxxxx | ||
Virus xxxxxxxxxxxxx typu 1 (xxxxxxxxxxxx) | 40 antigenních X xxxxxxxx | ||
Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) | 8 antigenních X xxxxxxxx | ||
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) | 32 xxxxxxxxxxx X xxxxxxxx | ||
1m) xxxxxxxx xxxxx proti xxxxxxxxxxx:
Bacillus Calmette Xxxxxx (xxxxxxxxxx) 100 000 - 300 000 X.X.* (xxxx Copenhagen 1331)
*X.X. = xxxx xxxxxxx
1x) očkovací xxxxx xxxxx virové xxxxxxxxxx X pro xxxxx xxxxxxxx xx xxxxxxxxxxxx programu:
Antigenum xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X obsahující 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (MPL) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx zvláštní xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx B
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
Virus rabiei xxxxxxxxxxx (kmen Xxxxxx xxxxxx PM/WI 38&xxxx;1503-3X xxxx xxxx rovno 2,5 mezinárodních xxxxxxxx x 1 dávce (0,5 xx)
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) očkovací xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx pro xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx xxxxxxx pro xxxx:
Virus xxxxxxxxx A xxxxxxxxxxx
Ministr:
xxx. XXXx. Heger, XXx., x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 325/2011 Xx. nabyl xxxxxxxxx dnem 24.11.2011.
Xx xxx xxxxxxxx xxxxxx předpis xxxxx xxxxx či xxxxxxxxx.
Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx xxxxxxxx xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.